OTC医薬品と栄養補助食品の世界市場レポート 2025年

OTC医薬品と栄養補助食品市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.2％で、4,707億米ドルに成長します。予測期間の成長は、個別化された栄養とサプリメント、栄養補助食品のイノベーション、機能性食品の拡大、世界の健康危機と備え、ウェルネスに対する政府の取り組みに起因すると考えられます。予測期間の主な動向には、製品イノベーション、クリーンラベルと天然成分、カンナビジオール（CBD）と麻ベースの製品、持続可能で環境に優しいパッケージング、パートナーシップとコラボレーションなどが含まれます。

医薬品研究開発費の増加は、今後のOTC医薬品と栄養補助食品市場を強化すると予想されます。研究開発投資とは、企業が製品の開発、設計、改良のために支出する費用を指します。研究開発投資の増加は、一般用医薬品や栄養補助食品を開発・製剤化する際の技術革新や生産性の向上につながります。例えば、ルクセンブルクに本部を置く欧州連合（EU）の統計局であるユーロスタットは2023年12月、2022年のEUの研究開発（R&D）支出は3,520億ユーロ（3,844億2,000万米ドル）に上り、前年の3,310億ユーロ（3,614億8,000万米ドル）から6.34％増加したと報告しました。したがって、医薬品の研究開発費の増加がOTC医薬品と栄養補助食品市場を活性化しています。

栄養補助食品に対する需要の高まりが、OTC医薬品と栄養補助食品市場の拡大を牽引すると予想されます。栄養補助食品は、ビタミン、ミネラル、ハーブ、アミノ酸、または食生活の改善を目的としたその他の栄養成分を含む製品です。OTCの分類により、栄養補助食品は処方箋なしで販売できるようになり、薬局、スーパーマーケット、オンライン・プラットフォームなど、さまざまな小売チャネルで入手しやすくなった。この利用しやすさが消費者の選択を促し、市場の成長に寄与しています。例えば、2024年1月、アクティブ・ニュートリションのデータとインサイトを専門とする英国のニュートリション・インテグレーテッド社のレポートによると、欧州では、2022年1月以降、透明なプロテインパウダー製品の種類が159%増加しています。さらに、アマゾンの販売データによると、英国における透明プロテインパウダーの消費者購入は、2023年には2022年比で216％急増しました。したがって、栄養補助食品に対する需要の高まりがOTC医薬品と栄養補助食品市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界OTC医薬品と栄養補助食品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のOTC医薬品と栄養補助食品市場：成長率分析
• 世界のOTC医薬品と栄養補助食品市場の実績：規模と成長, 2019-2024
• 世界のOTC医薬品と栄養補助食品市場の予測：規模と成長, 2024-2029, 2034F
• 世界OTC医薬品と栄養補助食品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のOTC医薬品と栄養補助食品市場：カテゴリ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンと栄養補助食品
• 咳止め・風邪薬
• 鎮痛剤
• 胃腸薬
• 睡眠補助剤
• 耳用製品
• イボ除去剤
• 口腔ケア製品
• 眼科用製品
• その他のカテゴリー
• 世界のOTC医薬品と栄養補助食品市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• ハードカプセル
• 粉末
• 軟膏
• ソフトカプセル
• 液体
• その他の剤形
• 世界のOTC医薬品と栄養補助食品市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬局
• 食料品店
• ビタミンと健康食品店
• オンライン薬局
• 世界のOTC医薬品と栄養補助食品市場、ビタミンおよび栄養補助食品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マルチビタミン
• ミネラルサプリメント
• ハーブサプリメント
• オメガ3脂肪酸
• プロバイオティクス
• 特殊サプリメント
• 世界のOTC医薬品と栄養補助食品市場、咳止め・風邪薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 咳止め薬
• 去痰薬
• 充血除去薬
• 組み合わせ製品
• 世界のOTC医薬品と栄養補助食品市場、鎮痛剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アセトアミノフェン
• NSAIDs
• 局所鎮痛剤
• 世界のOTC医薬品と栄養補助食品市場、消化器関連製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 制酸剤
• 下剤
• 下痢止め
• プロトンポンプ阻害剤
• 世界のOTC医薬品と栄養補助食品市場睡眠補助剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メラトニン
• 抗ヒスタミン薬
• ハーブ睡眠補助剤
• 世界のOTC医薬品と栄養補助食品市場耳用製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 耳垢除去補助具
• 感染症用の点耳薬
• 耳のかゆみ止め製品
• 世界のOTC医薬品と栄養補助食品市場、タイプ別イボ除去剤のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• サリチル酸製品
• 凍結療法キット
• 世界のOTC医薬品と栄養補助食品市場、口腔ケア製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• マウスウォッシュ
• 歯磨き粉
• 爽快感のための口腔洗浄剤
• 世界のOTC医薬品と栄養補助食品市場眼科用製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 人工涙液
• アレルギー用目薬
• 赤みの緩和
• 世界のOTC医薬品と栄養補助食品市場、その他のカテゴリのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚疾患の局所治療
• 救急用品

第7章 地域別・国別分析

• 世界のOTC医薬品と栄養補助食品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のOTC医薬品と栄養補助食品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• OTC医薬品と栄養補助食品市場：競合情勢
• OTC医薬品と栄養補助食品市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A
• Abbott Laboratories Inc
• GSK plc
• Gilead Sciences Inc.
• Reckitt Benckiser Plc.
• Teva Pharmaceutical Industries Ltd.
• Alcon Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Church & Dwight Co Inc
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Glenmark Pharmaceuticals Limited
• Alkem Laboratories Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• OTC医薬品と栄養補助食品市場2029：新たな機会を提供する国
• OTC医薬品と栄養補助食品市場2029：新たな機会を提供するセグメント
• OTC医薬品と栄養補助食品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

OTC drugs are pharmaceuticals that can be purchased over the counter and are used to treat common medical conditions. In contrast, dietary supplements are formulated to enhance the intake of specific nutrients or bioactive compounds in the diet and are not intended to treat, prevent, or cure diseases. OTC drugs provide rapid relief from symptoms and address specific health concerns, while dietary supplements offer additional nutritional support to promote overall wellness and strengthen the body's health maintenance. Together, they contribute to a holistic approach to self-care and preventive health.

The primary categories within OTC drugs and dietary supplements include vitamin and dietary supplements, cough and cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, and others. Vitamin and dietary supplements consist of chemical substances utilized in minimal quantities for diverse metabolic processes, contributing to overall health and aiding in the management of various health issues. These products are accessible in various forms such as tablets, hard capsules, powders, ointments, soft capsules, liquids, and more, and are conveniently found in pharmacies, grocery stores, vitamin and health food stores, as well as online pharmacies.

The OTC drug and dietary supplement market research report is one of a series of new reports from The Business Research Company that provides OTC drug and dietary supplement market statistics, including OTC drug and dietary supplement industry global market size, regional shares, competitors with an OTC drug and dietary supplement market share, detailed OTC drug and dietary supplement market segments, market trends and opportunities, and any further data you may need to thrive in the OTC drug and dietary supplement industry. This OTC drug and dietary supplement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The OTC drug and dietary supplement market size has grown strongly in recent years. It will grow from $332.52 billion in 2024 to $355.94 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to an increased number of fitness enthusiasts, demographic shifts and aging population, regulatory approvals and safety standards, pharmacy and retail expansions, and marketing and advertising strategies

The OTC drug and dietary supplement market size is expected to see strong growth in the next few years. It will grow to $470.7 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to personalized nutrition and supplements, nutraceutical innovations, expansion of functional foods, global health crises and preparedness, and government initiatives for wellness. Major trends in the forecast period include product innovations, clean label and natural ingredients, cannabidiol (CBD) and hemp-based products, sustainable and eco-friendly packaging, partnerships and collaborations.

An increase in pharmaceutical R&D expenditure is anticipated to enhance the OTC drug and dietary supplement market in the future. R&D investment refers to the costs incurred by a company for the development, design, and improvement of its products. Higher spending can lead to greater innovation and productivity in creating and formulating OTC drugs and dietary supplements. For example, in December 2023, Eurostat, the statistical office of the European Union based in Luxembourg, reported that in 2022, the EU's research and development (R&D) expenditure rose to €352 billion ($384.42 billion), representing a 6.34% increase from €331 billion ($361.48 billion) the previous year. Therefore, the rise in pharmaceutical R&D expenditure is fueling the OTC drug and dietary supplement market.

The growing demand for dietary supplements is expected to drive the expansion of the OTC drug and dietary supplement market. Dietary supplements are products that contain vitamins, minerals, herbs, amino acids, or other dietary components intended to enhance one's diet. The OTC classification allows dietary supplements to be sold without a prescription, improving their availability across various retail channels, including pharmacies, supermarkets, and online platforms. This accessibility encourages consumer choice and contributes to market growth. For instance, in January 2024, a report from Nutrition Integrated, a UK-based company specializing in data and insights for active nutrition, indicated that in Europe, the variety of clear protein powder products has increased by 159% since January 2022. Furthermore, sales data from Amazon shows that consumer purchases of clear protein powders in the UK surged by 216% in 2023 compared to 2022. Therefore, the rising demand for dietary supplements is driving growth in the OTC drug and dietary supplement market.

The OTC drug and dietary supplement market is experiencing a significant trend towards product innovation, with major companies actively developing novel products to enhance their market positions. An example of this trend is evident in the actions of Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical industry player. In July 2022, the company introduced over-the-counter (OTC) Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg extended-release tablets. This OTC product serves as both an oral antihistamine and nasal decongestant, offering temporary relief for nasal and sinus congestion caused by colds or allergies. The launch of such innovative products contributes to the expansion of OTC portfolios, addressing specific health needs.

Major companies are strategically focusing on groundbreaking innovations, such as the development of oral contraceptive pills (OCP), to fortify their market presence. Perrigo Company PLC, an Ireland-based self-care company, achieved a noteworthy milestone in July 2023 when the U.S. Food and Drug Administration (FDA) granted approval for Opill, a progestin-only daily oral contraceptive, to be available over-the-counter (OTC) for all ages. This landmark decision marked Opill as the first-ever OTC accessible birth control pill in the United States. Perrigo's CEO, Patrick Lockwood-Taylor, emphasized the historical significance of this development for women's health, highlighting Opill's potential to revolutionize access to contraception. The approval underscores Perrigo's commitment to impactful solutions that enhance lives, representing a significant advancement in women's health.

In June 2022, Glenmark Pharmaceuticals Ltd., an India-based biopharmaceutical company, bolstered its presence in the OTC market in the United States by acquiring specific over-the-counter approved generic versions of drugs from Wockhardt Ltd. This undisclosed acquisition from Wockhardt Ltd., an India-based pharmaceutical and biotechnology company, further positions Glenmark Pharmaceuticals in the competitive OTC drug and dietary supplement market, demonstrating a commitment to expansion and strategic growth initiatives.

Major companies operating in the OTC drug and dietary supplement market include Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Inc, GSK plc, Gilead Sciences Inc., Reckitt Benckiser Plc., Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Church & Dwight Co Inc, Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Cipla Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd, Nutraceutical International Corporation, Procter & Gamble Health Limited, Reese Pharmaceutical Company, UPM Pharmaceuticals Inc, Gemini Pharmaceuticals Inc., Pharmavite LLC, Now Health Group Inc., Alfresa Pharma Corporation

North America was the largest region in the OTC drug and dietary supplement market in 2024. The regions covered in the otc drug and dietary supplement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the otc drug and dietary supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The OTC drug and dietary supplement market consist of sales of pain relievers, omega-3 fatty acids, probiotics, and herbal supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

OTC Drug And Dietary Supplement Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on otc drug and dietary supplement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for otc drug and dietary supplement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The otc drug and dietary supplement market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Category: Vitamin And Dietary Supplements; Cough And Cold Products; Analgesics; Gastrointestinal Products; Sleep Aids; Otic Products; Wart Removers; Mouth Care Products; Ophthalmic Products; Other Categories
• 2) By Dosage Form: Tablets; Hard Capsules; Powders; Ointments; Soft Capsules; Liquids; Other Dosage Forms
• 3) By Application: Pharmacies; Grocery Stores; Vitamin And Health Food Stores; Online Pharmacies
• Subsegments:
• 1) By Vitamin And Dietary Supplements: Multivitamins; Mineral Supplements; Herbal Supplements; Omega-3 Fatty Acids; Probiotics; Specialty Supplements
• 2) By Cough And Cold Products: Cough Suppressants; Expectorants; Decongestants; Combination Products
• 3) By Analgesics: Acetaminophen; NSAIDs; Topical Analgesics
• 4) By Gastrointestinal Products: Antacids; Laxatives; Antidiarrheals; Proton Pump Inhibitors
• 5) By Sleep Aids: Melatonin; Antihistamines; Herbal Sleep Aids
• 6) By Otic Products: Ear Wax Removal Aids; Ear Drops For Infections; Anti-itch Ear Products
• 7) By Wart Removers: Salicylic Acid Products; Cryotherapy Kits
• 8) By Mouth Care Products: Mouthwashes; Toothpastes; Oral Rinses For Freshness
• 9) By Ophthalmic Products: Artificial Tears; Allergy Eye Drops; Redness Relievers
• 10) By Other Categories: Nutraceuticals; Topical Treatments For Skin Conditions; First Aid Products
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. OTC Drug And Dietary Supplement Market Characteristics

3. OTC Drug And Dietary Supplement Market Trends And Strategies

4. OTC Drug And Dietary Supplement Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global OTC Drug And Dietary Supplement Growth Analysis And Strategic Analysis Framework

• 5.1. Global OTC Drug And Dietary Supplement PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global OTC Drug And Dietary Supplement Market Growth Rate Analysis
• 5.4. Global OTC Drug And Dietary Supplement Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global OTC Drug And Dietary Supplement Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global OTC Drug And Dietary Supplement Total Addressable Market (TAM)

6. OTC Drug And Dietary Supplement Market Segmentation

• 6.1. Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin And Dietary Supplements
• Cough And Cold Products
• Analgesics
• Gastrointestinal Products
• Sleep Aids
• Otic Products
• Wart Removers
• Mouth Care Products
• Ophthalmic Products
• Other Categories
• 6.2. Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Hard Capsules
• Powders
• Ointments
• Soft Capsules
• Liquids
• Other Dosage Forms
• 6.3. Global OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacies
• Grocery Stores
• Vitamin And Health Food Stores
• Online Pharmacies
• 6.4. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Vitamin And Dietary Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multivitamins
• Mineral Supplements
• Herbal Supplements
• Omega-3 Fatty Acids
• Probiotics
• Specialty Supplements
• 6.5. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Cough And Cold Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cough Suppressants
• Expectorants
• Decongestants
• Combination Products
• 6.6. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acetaminophen
• NSAIDs
• Topical Analgesics
• 6.7. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Gastrointestinal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antacids
• Laxatives
• Antidiarrheals
• Proton Pump Inhibitors
• 6.8. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Sleep Aids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Melatonin
• Antihistamines
• Herbal Sleep Aids
• 6.9. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Otic Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ear Wax Removal Aids
• Ear Drops For Infections
• Anti-itch Ear Products
• 6.10. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Wart Removers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Salicylic Acid Products
• Cryotherapy Kits
• 6.11. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Mouth Care Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mouthwashes
• Toothpastes
• Oral Rinses For Freshness
• 6.12. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Ophthalmic Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Tears
• Allergy Eye Drops
• Redness Relievers
• 6.13. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Other Categories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Treatments For Skin Conditions
• First Aid Products

7. OTC Drug And Dietary Supplement Market Regional And Country Analysis

• 7.1. Global OTC Drug And Dietary Supplement Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global OTC Drug And Dietary Supplement Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific OTC Drug And Dietary Supplement Market

• 8.1. Asia-Pacific OTC Drug And Dietary Supplement Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China OTC Drug And Dietary Supplement Market

• 9.1. China OTC Drug And Dietary Supplement Market Overview
• 9.2. China OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India OTC Drug And Dietary Supplement Market

• 10.1. India OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan OTC Drug And Dietary Supplement Market

• 11.1. Japan OTC Drug And Dietary Supplement Market Overview
• 11.2. Japan OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia OTC Drug And Dietary Supplement Market

• 12.1. Australia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia OTC Drug And Dietary Supplement Market

• 13.1. Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea OTC Drug And Dietary Supplement Market

• 14.1. South Korea OTC Drug And Dietary Supplement Market Overview
• 14.2. South Korea OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe OTC Drug And Dietary Supplement Market

• 15.1. Western Europe OTC Drug And Dietary Supplement Market Overview
• 15.2. Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK OTC Drug And Dietary Supplement Market

• 16.1. UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany OTC Drug And Dietary Supplement Market

• 17.1. Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France OTC Drug And Dietary Supplement Market

• 18.1. France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy OTC Drug And Dietary Supplement Market

• 19.1. Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain OTC Drug And Dietary Supplement Market

• 20.1. Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe OTC Drug And Dietary Supplement Market

• 21.1. Eastern Europe OTC Drug And Dietary Supplement Market Overview
• 21.2. Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia OTC Drug And Dietary Supplement Market

• 22.1. Russia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America OTC Drug And Dietary Supplement Market

• 23.1. North America OTC Drug And Dietary Supplement Market Overview
• 23.2. North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA OTC Drug And Dietary Supplement Market

• 24.1. USA OTC Drug And Dietary Supplement Market Overview
• 24.2. USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada OTC Drug And Dietary Supplement Market

• 25.1. Canada OTC Drug And Dietary Supplement Market Overview
• 25.2. Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America OTC Drug And Dietary Supplement Market

• 26.1. South America OTC Drug And Dietary Supplement Market Overview
• 26.2. South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil OTC Drug And Dietary Supplement Market

• 27.1. Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East OTC Drug And Dietary Supplement Market

• 28.1. Middle East OTC Drug And Dietary Supplement Market Overview
• 28.2. Middle East OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa OTC Drug And Dietary Supplement Market

• 29.1. Africa OTC Drug And Dietary Supplement Market Overview
• 29.2. Africa OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. OTC Drug And Dietary Supplement Market Competitive Landscape And Company Profiles

• 30.1. OTC Drug And Dietary Supplement Market Competitive Landscape
• 30.2. OTC Drug And Dietary Supplement Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. OTC Drug And Dietary Supplement Market Other Major And Innovative Companies

• 31.1. Sanofi S.A
• 31.2. Abbott Laboratories Inc
• 31.3. GSK plc
• 31.4. Gilead Sciences Inc.
• 31.5. Reckitt Benckiser Plc.
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Alcon Inc.
• 31.8. Bausch Health Companies Inc.
• 31.9. Sun Pharmaceutical Industries Ltd.
• 31.10. Church & Dwight Co Inc
• 31.11. Perrigo Company plc
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Cipla Limited
• 31.14. Glenmark Pharmaceuticals Limited
• 31.15. Alkem Laboratories Ltd

32. Global OTC Drug And Dietary Supplement Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The OTC Drug And Dietary Supplement Market

34. Recent Developments In The OTC Drug And Dietary Supplement Market

35. OTC Drug And Dietary Supplement Market High Potential Countries, Segments and Strategies

• 35.1 OTC Drug And Dietary Supplement Market In 2029 - Countries Offering Most New Opportunities
• 35.2 OTC Drug And Dietary Supplement Market In 2029 - Segments Offering Most New Opportunities
• 35.3 OTC Drug And Dietary Supplement Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer